Drug industry consulting and contract research firm IQVIA reports that prescription drug sales at 340B-discounted prices grew 18.1% year-on-year from 2019 to 2020.
“Astonishingly, this represents an acceleration in 340B growth versus 2019,” the firm said in a March 31 blog post. In September 2020, it reported that 340B sales in 2019 were 17.1% greater than the year before.
Drug industry consulting and contract research firm IQVIA reports that prescription drug sales at 340B-discounted prices grew 18.1% year-on-year from 2019 to 2020.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
